Related content

The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A.   Davidson P.   Atkinson C.   Hart D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA

By Eppler E.   Horig H.   Kaufman H.L.   Groscurth P.   Filgueira L.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 184-193

Elsevier

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

By Kyte Jon   Kvalheim Gunnar   Lislerud Kari   thor Straten Per   Dueland Svein   Aamdal Steinar   Gaudernack Gustav  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 5, 2007-05 ,pp. : 659-675

Springer Publishing Company

Access to resources Recommend Favorite

Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines

By Ruben Jurjen   Ancker Willemijn   Bontkes Hetty   Westers Theresia   Hooijberg Erik   Ossenkoppele Gert   Gruijl Tanja   Loosdrecht Arjan  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite